Liver failure caused by intravenous amiodarone and effective intervention measures: A case report.
Zhouqian JiangChengfei ZhaoXiaoyun LiWenyan YiRuqing YanPublished in: Journal of clinical pharmacy and therapeutics (2022)
Amiodarone is a highly effective antiarrhythmic agent for the treatment and prevention of atrial and ventricular arrhythmias. Acute liver damage after intravenous amiodarone is rare but potentially harmful. Amiodarone loading should be adapted to the necessity of an immediate effect of the drug, and liver function should be monitored closely in critically ill patients. Timely stopped suspected drug and anti-inflammatory liver therapy may reduce the occurrence of drug-induced diseases.
Keyphrases
- drug induced
- liver failure
- liver injury
- hepatitis b virus
- adverse drug
- anti inflammatory
- high dose
- randomized controlled trial
- catheter ablation
- risk assessment
- atrial fibrillation
- pulmonary embolism
- stem cells
- emergency department
- intensive care unit
- mesenchymal stem cells
- replacement therapy
- bone marrow
- acute respiratory distress syndrome
- congenital heart disease
- electronic health record